Articles

Artificial intelligence systems have been previously used to predict post-operative complications in small studies and single institutions. Here we developed a robust artificial intelligence model that predicts the risk of having cardiac, pulmonary, thromboembolic, or septic complications after elective, non-cardiac, non-ambulatory surgery. We combined structured and unstructured electronic health record data from 3.5 million surgical encounters from 25 medical centers between 2009 and 2017. Our neural network model predicted postoperative comorbidities 15 to 80 times faster than classical models. As such, our model can be used to assess the risk of having a specific complication postoperatively in a fraction of a second. With our model, we believe clinicians will be able to identify high-risk surgical patients and use their good judgment to mitigate upcoming risks, ultimately improving patient outcomes [1].

The growing complexity and variability in healthcare delivery and costs within Medicare Advantage (MA) and Medicare Supplement (Medigap) plans present significant challenges for improving health outcomes and managing expenditures. Neural networks, a subset of artificial intelligence (AI), have shown considerable promise in optimizing healthcare processes, particularly in predictive modeling, personalized treatment recommendations, and risk stratification. This paper explores the application of neural networks in enhancing health outcomes within the context of Medicare Advantage and Supplement plans. We review how deep learning models can be leveraged to predict patient risk, optimize resource allocation, and identify at-risk populations for preventive interventions. Additionally, we discuss the potential for neural networks to improve claims processing, reduce fraud, and streamline administrative burdens. By integrating various data sources, including medical records, claims data, and demographic information, neural networks enable more accurate and efficient decision-making processes. Ultimately, this approach can lead to better patient care, reduced healthcare costs, and improved satisfaction for beneficiaries of these programs. The paper concludes by highlighting the current limitations, ethical considerations, and future directions for AI adoption in the Medicare Advantage and Supplement sectors.